IP Library Granted Patent US 11,648,348
Granted Patent B2
US 11,648,348 · App. 17/114,252 · Granted May 16, 2023

Medicament delivery device

Inventor: Oscar Alexandersson (Hanine, SE)
Assignee: SHL MEDICAL AG
A61M5/20A61M5/2033A61M5/3157A61M5/3202A61M5/326A61M2005/206A61M2005/2013A61M2005/2026A61M2205/581A61M2205/582A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,648,348
App. No.
17/114,252
Granted
May 16, 2023
Kind
B2
Abstract

A medicament delivery device includes a generally elongated tubular housing having opposite proximal and distal parts; a needle shield sleeve slidably and coaxially arranged inside the housing with a proximal part of the sleeve protruding a distance outside the proximal part of the housing; a syringe carrier mechanism having a syringe carrier slidably and coaxially arranged within the needle shield sleeve, a syringe having a stopper, a medicament, and a needle, the syringe being coaxially arranged within the syringe carrier; and a holding member connected to the syringe carrier; a first activator member an a second activator member; a drive mechanism adapted to accumulate a drive force for moving the syringe carrier mechanism in a first step and a second step. The second activator member is arranged within an information device for producing audible, visual, and/or tactile feedback to a user about a completed injection.

Claims (35)

1. An end of injection notification assembly for use in an injection device, the assembly comprising:

an activator configured to slide axially within a distal end of a housing of the injection device;

an information member positioned on the activator and configured to provide information indicating that an injection of a medicament contained within the injection device has been completed; and

a compression spring having a distal end engaged with the activator such that at the end of the injection the spring biases the activator in a distal direction.

2. The assembly device of claim 1 , wherein the activator has a distal transversal end wall and the information member is attached to the transversal wall.

3. The assembly device of claim 1 , wherein the compression spring is pre-tensioned prior to starting the injection.

4. The assembly device of claim 1 , further comprising a second spring that exerts a biasing force on the activator such that when the injection is completed the information member will move distally and will strike an inside surface of the housing of the injection device.

5. The assembly device of claim 4 , wherein the second spring acts on an inner surface of a distal transversal end wall of the activator to move the activator axially relative to the housing of the injection device.

6. The assembly device of claim 1 , wherein the information member will protrude through an opening in the distal end of the housing when the injection is completed.

7. The assembly device of claim 1 , where the information member provides a visual signal when the injection is completed.

8. The assembly device of claim 1 , wherein the activator provides an audible signal when the injection is completed.

9. The assembly device of claim 1 , wherein the activator provides a tactile signal when the injection is completed.

10. An injection device, comprising:

a tubular housing,

a syringe carrier arranged within the tubular housing, the syringe carrier configured to carry a syringe, the syringe comprising a stopper, a medicament, and a needle,

a needle shield sleeve slidably arranged with respect to the tubular housing and protruding a distance outside a front end of the tubular housing,

a compression spring configured to bias the needle shield sleeve, and

an information member arranged to provide information indicating that an injection of the medicament contained within the syringe has been completed,

wherein the compression spring is arranged between the needle shield sleeve and the information member.

11. The injection device of claim 10 , wherein the compression spring is pre-tensioned prior to starting the injection.

12. The injection device of claim 10 , where the information member is positioned on a distal end of an activator that is slidably arranged within the tubular housing.

13. The injection device of claim 12 , wherein the compression spring biases the activator in a distal direction when the injection is completed.

14. The injection device of claim 12 , wherein a distal end of the compression spring is engaged with an outer surface of the activator such that the compression spring will move the activator in a distal direction upon completion of the injection.

15. An injection device, comprising:

a tubular housing,

a syringe carrier arranged within the tubular housing, the syringe carrier configured to carry a syringe, the syringe comprising a stopper, a medicament, and a needle,

a needle shield sleeve slidably arranged with respect to the tubular housing and protruding a distance outside a front end of the tubular housing,

a plunger rod arranged to act on the stopper of the syringe,

a first compression spring arranged to drive the plunger rod,

an activator member capable of releasably holding the plunger rod,

a second compression spring arranged between the needle shield sleeve and the activator member, and

an information member attached to the activator member, the information member arranged to provide information indicating that an injection of the medicament contained within the syringe has been completed.

16. The injection device of claim 15 , wherein a distal end of the second compression spring abuts and biases the activator in a distal direction.

17. The injection device of claim 15 , where the second compression spring is pre-tensioned prior to beginning the injection.

18. The injection device of claim 15 , Where after completion of the injection a distal end of the second compression spring moves the activator distally such that the information member will provide a tactile or visual signal that the injection is completed.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2020
From: ALEXANDERSSON, OSCAR
To: SHL GROUP AB
Reel/Frame 054574/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2020
From: SHL GROUP AB
To: SHL MEDICAL AG
Reel/Frame 054574/0369 →
Priority Claims (1)
SE 0950807-8 · Oct 30, 2009 · national
Continuity (9)
Continuation 16774347 · Jan 28, 2020
Continuation 15474872 · Mar 30, 2017
Continuation 15286880 · Oct 6, 2016
Continuation 14993736 · Jan 12, 2016
Continuation 14747869 · Jun 23, 2015
Continuation 13858692 · Apr 8, 2013
Continuation 13500913
Provisional Application 61249675 · Oct 8, 2009
Related Publication 20210085871A1 · Mar 25, 2021
Cited By (5)
US 12,208,245 US 12,226,614 US 12,440,625 US 12,611,507 US 12,616,795